High-purity bile acid derivatives for specialized pharmaceutical and industrial applications.
As the economic engine of East Africa, Kenya's pharmaceutical sector is undergoing a profound transformation. Under the "Big Four Agenda" and "Vision 2030," the Kenyan government has prioritized local manufacturing to reduce dependency on expensive imports. The Cholic acid series, fundamental in the production of hepatobiliary drugs and advanced biochemical research, has seen a 25% increase in demand within the Nairobi and Mombasa industrial hubs over the last three years.
Our role as a primary exporter to Kenya extends beyond mere logistics. We provide the "Information Gain" necessary for Kenyan manufacturers to transition from simple formulation (Fill & Finish) to complex active pharmaceutical ingredient (API) integration. Cholic acid derivatives are increasingly used in local livestock nutrition, particularly in the growing aquaculture and poultry sectors in the Lake Victoria region, where they function as essential emulsifiers for lipid digestion.
Kenya acts as the regulatory benchmark for the EAC. Adopting high-purity Cholic acid ensures compliance with the Pharmacy and Poisons Board (PPB) standards.
Integration with Kenya's burgeoning cosmetics industry for fat-dissolving treatments using high-grade Deoxycholic Acid.
With Mombasa as the gateway, our China-Kenya supply chain provides a 15-day lead time advantage compared to European competitors.
Chengdu Chenlv Herb Co., Ltd. (referred to as "Chenlv Herb") was established in 2012 as a high-tech enterprise specializing in the R&D, production, and sales of botanical extracts and natural pharmaceutical ingredients. Committed to providing high-purity, highly active, and premium-quality natural raw materials, the company serves diverse industries, including pharmaceuticals, health supplements, food, and cosmetics.
Our manufacturing facility leverages low-temperature enzymatic hydrolysis and gradient solvent crystallization to ensure that the Cholic acid series maintains a purity level of >99%. For the Kenyan market, this translates to higher stability in tropical storage conditions and reduced degradation during the inland transport from Mombasa to Nairobi.
Supply chain efficiency is our competitive edge. By utilizing the "Belt and Road" maritime routes, we offer Kenyan importers a tiered pricing structure that includes ODM/OEM options for local brands. Our resilience is built upon a dual-sourcing raw material strategy, ensuring that even during global fluctuations, the supply of Ox Bile Powder and Ursodeoxycholic Acid remains uninterrupted for our East African partners.
Driven by the concept of "homology of medicine and food", plant extracts are core for health care development.
From ancient books to modern drugs, extracts occupy a prominent position due to natural active ingredients.
Plant extracts are favorites in the cosmetics industry due to mildness and biocompatibility.
Custom molecular modification of bile acids to suit specific drug delivery systems required by Kenyan pharmaceutical labs.
Certified by ISO9001, ISO22000, HALAL, KOSHER, and FDA. Fully compliant with Kenyan regulatory frameworks.
Automated production lines in Chengdu ensure mass production capacity with zero-defect quality control.
The next decade of the Cholic acid series in Kenya will be defined by Biotechnology Integration. We are currently developing synthetic biology-derived bile acids that bypass animal sourcing, aligning with global sustainability trends and the specific Halal requirements of the East African community. Our roadmap includes the establishment of a local technical support office in Nairobi to provide real-time formulation troubleshooting for our clients.
A: The primary advantage is the combination of "Scale Economy" and "Logistical Proximity." China produces over 70% of the world's bile acid derivatives. Our factory in Chengdu offers direct-to-port shipping to Mombasa, ensuring that Kenyan buyers receive the freshest batches with maximum shelf life, which is critical given the local climate.
A: Yes. We provide a full dossier of documentation, including COA (Certificate of Analysis), MSDS, and GMP compliance certificates. Our regulatory team has extensive experience assisting Kenyan partners in the drug registration process.
A: Absolutely. Taurochenodeoxycholic acid and its salts are excellent growth promoters for tilapia and shrimp, which are major aquaculture species in Kenya. They improve feed conversion ratios (FCR) by enhancing fat emulsification.
A: We utilize climate-controlled shipping containers and specialized vacuum-sealed aluminum foil packaging to prevent moisture absorption and thermal degradation during the equatorial transit.
A full range of bile acid derivatives for global and local Kenyan distribution.
Ready to elevate your Kenyan industrial or pharmaceutical venture? Contact our growth directors today for a custom quote and technical whitepaper.
Get Started Now
Chenlv Herb
